Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5675-5680

  Ding, Jing ^a   Tang, Jie ^a   Chen, Xin ^a   Men, Hai Tao ^a   Luo, Wu Xia ^a   Du, Yang ^a   Ge, Jun ^a   Li, Cong ^a   Chen, Ye ^a   Cheng, Ke ^a   Qiu, Meng ^a   Liu, Ji Yan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Early event; Insulin; Insulin receptor; like growth factor; Non small cell lung cancer

Indexed keywords

INSULIN RECEPTOR SUBSTRATE; SOMATOMEDIN;

AGED; FEMALE; GENETICS; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NON SMALL CELL LUNG CANCER; PATHOLOGY; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 84890511439     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5675     Document Type: Article

References (32)

1. Arif JM, Al-Saif AM, Al-Karrawi MA, Al-Sagair OA (2011). Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview. Asian Pac J Cancer Prev, 12, 589-92.
2. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011). Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer, 128, 635-43.
3. Arcaro A (2013). Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharmacol, 4, 30.
4. Barone BB, Yeh HC, Snyder CF, et al (2008). Long-term allcause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA, 300, 2754-64.
5. Chott A, Sun Z, Morganstern D, et al (1999). Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol, 155, 1271-9.
6. Currie CJ, Poole CD, Jenkins-Jones S, et al (2012). Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care, 35, 299-304.
7. Elena JW, Steplowski E, Yu K, et al (2013). Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control, 24, 13-25.
8. Fidler MJ, Shersher DD, Borgia JA, Bonomi P (2012). Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls. Ther Adv Med Oncol, 4, 51-60.
9. Ferguson R, Gallagher EJ, Cohen D, et al (2013). Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2/Neu-mediated breast cancer. Endocr Relat Cancer, 20, 391-401.
10. Gibson SL, Ma Z, Shaw LM, et al (2007). Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle, 6, 631-7.
11. Herberger B, Puhalla H, Lehnert M (2007). Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma. Clin Cancer Res, 13, 4795-9.
12. Hanbali A, Al-Khasawneh K, Cole-Johnson C, Divine G, Haytham Ali (2007). Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med, 167, 513.
13. He J, Stram DO, Kolonel LN, et al (2010). The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer, 103, 120-6.
14. Hardefeldt PJ, Edirimanne S, Eslick GD (2012). Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer, 19, 793-803.
15. Hwang A, Narayan V, Yang YX (2013). Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer, 119, 404-10.
16. Jackson JG, Zhang X, Yoneda T, Yee D (2001). Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene, 20, 7318-25.
17. Kornmann M, Maruyama H, Bergmann U, et al (1998). Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res, 58, 4250-4.
18. Kurishima K, Satoh H (2012). Prolonged survival in lung cancer patients with diabetes mellitus. J Thorac Oncol, 7, e17-8.
19. LeRoith D, Roberts CT (2003). The insulin-like growth factor system and cancer. Cancer Letters, 195, 127-37.
20. Lee JY, Jeon I, Lee JM, Yoon JM, Park SM (2013). Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies. Eur J Cancer, 49, 2411-23.
21. Pavelic J, Krizanac S, Kapitanovic S, et al (2005). The consequences of insulin-like growth factors/receptors dysfunction in lung cancer. Am J Respir Cell Mol Biol, 32, 65-71.
22. Rajpathak SN, Gunter MJ, Wylie-Rosett J, et al (2009). The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev, 25, 3-12.
23. Satyamoorthy K., Li G, Vaidya B, Patel D, Herlyn M (2001). Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogenactivated protein kinase and beta-catenin pathways. Cancer Res, 61, 7318-24.
24. Shaw LM (2011). The insulin receptor substrate (IRS) proteins: At the intersection of metabolism and cancer. Cell Cycle, 10, 1750-6.
25. Siegel R, Naishadham D, Jemal A, et al (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
26. Tan BX, Yao WX, Ge J, et al (2011). Prognostic influence of metformin as first-line chemotherapy for advanced non-small cell lung cancer in patients with type 2 diabetes. Cancer, 117, 5103-11.
27. Varlotto J, Medford-Davis LN, Recht A, et al (2012). Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer, 75, 381-90.
28. Wu J, Tseng YD, Xu CF, et al (2008). Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat Struct Mol Biol, 15, 251-8.
29. Wang C, Wang X, Gong G, et al (2012). Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer, 130, 1639-48.
30. Wang T, Ning G, Bloomgarden Z (2013). Diabetes and Cancer Relationships. J Diabetes, doi: 10.1111/1753-0407.12057
31. Walker JJ, Brewster DH, Colhoun HM, et al (2013). Causespecific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007). Diabetologia, 56, 1531-41.
32. Zhang ZH, Su PY, Hao JH, Sun YH (2013). The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer, 23, 294-303.